b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31625136</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>07</Month>\n            <Day>27</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>07</Month>\n            <Day>27</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1365-2141</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>188</Volume>\n                    <Issue>4</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>02</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>British journal of haematology</Title>\n                <ISOAbbreviation>Br. J. Haematol.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Autoimmune conditions and primary central nervous system lymphoma risk among older adults.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>516-521</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1111/bjh.16222</ELocationID>\n            <Abstract>\n                <AbstractText>Primary central nervous system lymphoma (PCNSL) risk is highly increased in immunosuppressed individuals, such as those with human immunodeficiency virus infection and solid organ transplant recipients, but rates are increasing among immunocompetent older adults (age \xe2\x89\xa565\xc2\xa0years). We utilized data from a large, nationally-representative cohort of older adults in the United States and found that PCNSL is significantly associated with systemic lupus erythematosus, polyarteritis nodusa, autoimmune hepatitis, myasthenia gravis and uveitis. Immunosuppressive drugs given to treat these conditions may increase PCNSL risk, but these associations cannot explain the observed temporal increase in PCNSL rates, given the low prevalence of these conditions.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2019 British Society for Haematology and John Wiley &amp; Sons Ltd.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Mahale</LastName>\n                    <ForeName>Parag</ForeName>\n                    <Initials>P</Initials>\n                    <Identifier Source="ORCID">0000-0003-1285-3310</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Herr</LastName>\n                    <ForeName>Megan M</ForeName>\n                    <Initials>MM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Engels</LastName>\n                    <ForeName>Eric A</ForeName>\n                    <Initials>EA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pfeiffer</LastName>\n                    <ForeName>Ruth M</ForeName>\n                    <Initials>RM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Shiels</LastName>\n                    <ForeName>Meredith S</ForeName>\n                    <Initials>MS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>Z99 CA999999</GrantID>\n                    <Acronym>ImNIH</Acronym>\n                    <Agency>Intramural NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <Acronym>CA</Acronym>\n                    <Agency>NCI NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016448">Multicenter Study</PublicationType>\n                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>\n                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>17</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Br J Haematol</MedlineTA>\n            <NlmUniqueID>0372544</NlmUniqueID>\n            <ISSNLinking>0007-1048</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName>\n                <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016543" MajorTopicYN="Y">Central Nervous System Neoplasms</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName>\n                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007166" MajorTopicYN="Y">Immunosuppressive Agents</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008228" MajorTopicYN="Y">Lymphoma, Non-Hodgkin</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">SEER-Medicare</Keyword>\n            <Keyword MajorTopicYN="Y">autoimmune conditions</Keyword>\n            <Keyword MajorTopicYN="Y">myasthenia gravis</Keyword>\n            <Keyword MajorTopicYN="Y">primary central nervous system lymphoma</Keyword>\n            <Keyword MajorTopicYN="Y">systemic lupus erythematosus</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>20</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>08</Month>\n                <Day>04</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pmc-release">\n                <Year>2021</Year>\n                <Month>02</Month>\n                <Day>01</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>19</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>7</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>19</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31625136</ArticleId>\n            <ArticleId IdType="doi">10.1111/bjh.16222</ArticleId>\n            <ArticleId IdType="pmc">PMC7012721</ArticleId>\n            <ArticleId IdType="mid">NIHMS1050211</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1069-78</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23595542</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 1991 Oct 19;338(8773):969-73</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1681341</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2009 Jul 15;125(2):398-405</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19365835</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Transplant. 2018 Feb;18(2):453-461</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28805292</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurooncol. 2005 Aug;74(1):91-2</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16078114</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>AIDS. 2014 Sep 24;28(15):2313-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25111081</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lupus. 2017 Oct;26(11):1224-1227</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28152659</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Haematol. 2016 Aug;174(3):417-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27018254</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Epidemiol. 2011 Oct 1;174(7):860-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21821540</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncologist. 2011;16(11):1589-99</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22045784</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Med Care. 2002 Aug;40(8 Suppl):IV-3-18</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12187163</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Cancer. 2011 Oct 25;105(9):1414-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21915121</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2017 Jul 20;35(21):2410-2418</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28640701</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2014 Oct;25(10):2025-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25081899</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'